Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects
Nesfatin-1 is a novel anorexigenic regulatory peptide. The peptide is the N-terminal part of nucleobindin 2 (NUCB2) and is expressed in brain areas regulating feeding. Outside the brain, nesfatin-1 expression has been reported in adipocytes, gastric endocrine cells and islet cells. We studied NUCB2...
Saved in:
| Published in | Cell and tissue research Vol. 346; no. 3; pp. 393 - 405 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Berlin/Heidelberg
Springer-Verlag
01.12.2011
Springer Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Nesfatin-1 is a novel anorexigenic regulatory peptide. The peptide is the N-terminal part of nucleobindin 2 (NUCB2) and is expressed in brain areas regulating feeding. Outside the brain, nesfatin-1 expression has been reported in adipocytes, gastric endocrine cells and islet cells. We studied NUCB2 expression in human and rodent islets using immunocytochemistry, in situ hybridization and western blot. Furthermore, we investigated the potential influence of nesfatin-1 on secretion of insulin and glucagon in vitro and in vivo in mice and in INS-1 (832/13) cells. The impact of type 2 diabetes (T2D) and glucolipotoxicity on NUCB2 gene expression in human islets and its relationship to insulin secretory capacity and islet gene expression was studied using microarray. Nesfatin-1 immunoreactivity (IR) was abundant in human and rodent beta cells but absent in alpha, delta, PP and ghrelin cells. Importantly, in situ hybridization showed that NUCB2 mRNA is expressed in human and rat islets. Western blot analysis showed that nesfatin-1 IR represented full length NUCB2 in rodent islets. Human islet NUCB2 mRNA was reduced in T2D subjects but upregulated after culture in glucolipotoxic conditions. Furthermore, a positive correlation between NUCB2 and glucagon and insulin gene expression, as well as insulin secretory capacity, was evident. Nesfatin-1 enhanced glucagon secretion but had no effect on insulin secretion from mouse islets or INS-1 (832/13) cells. On the other hand, nesfatin-1 caused a small increase in insulin secretion and reduced glucose during IVGTT in mice. We conclude that nesfatin-1 is a novel glucagon-stimulatory peptide expressed in the beta cell and that its expression is decreased in T2D islets. |
|---|---|
| AbstractList | Nesfatin-1 is a novel anorexigenic regulatory peptide. The peptide is the N-terminal part of nucleobindin 2 (NUCB2) and is expressed in brain areas regulating feeding. Outside the brain, nesfatin-1 expression has been reported in adipocytes, gastric endocrine cells and islet cells. We studied NUCB2 expression in human and rodent islets using immunocytochemistry, in situ hybridization and western blot. Furthermore, we investigated the potential influence of nesfatin-1 on secretion of insulin and glucagon in vitro and in vivo in mice and in INS-1 (832/13) cells. The impact of type 2 diabetes (T2D) and glucolipotoxicity on NUCB2 gene expression in human islets and its relationship to insulin secretory capacity and islet gene expression was studied using microarray. Nesfatin-1 immunoreactivity (IR) was abundant in human and rodent beta cells but absent in alpha, delta, PP and ghrelin cells. Importantly, in situ hybridization showed that NUCB2 mRNA is expressed in human and rat islets. Western blot analysis showed that nesfatin-1 IR represented full length NUCB2 in rodent islets. Human islet NUCB2 mRNA was reduced in T2D subjects but upregulated after culture in glucolipotoxic conditions. Furthermore, a positive correlation between NUCB2 and glucagon and insulin gene expression, as well as insulin secretory capacity, was evident. Nesfatin-1 enhanced glucagon secretion but had no effect on insulin secretion from mouse islets or INS-1 (832/13) cells. On the other hand, nesfatin-1 caused a small increase in insulin secretion and reduced glucose during IVGTT in mice. We conclude that nesfatin-1 is a novel glucagon-stimulatory peptide expressed in the beta cell and that its expression is decreased in T2D islets. Nesfatin-1 is a novel anorexigenic regulatory peptide. The peptide is the N-terminal part of nucleobindin 2 (NUCB2) and is expressed in brain areas regulating feeding. Outside the brain, nesfatin-1 expression has been reported in adipocytes, gastric endocrine cells and islet cells. We studied NUCB2 expression in human and rodent islets using immunocytochemistry, in situ hybridization and western blot. Furthermore, we investigated the potential influence of nesfatin-1 on secretion of insulin and glucagon in vitro and in vivo in mice and in INS-1 (832/13) cells. The impact of type 2 diabetes (T2D) and glucolipotoxicity on NUCB2 gene expression in human islets and its relationship to insulin secretory capacity and islet gene expression was studied using microarray. Nesfatin-1 immunoreactivity (IR) was abundant in human and rodent beta cells but absent in alpha, delta, PP and ghrelin cells. Importantly, in situ hybridization showed that NUCB2 mRNA is expressed in human and rat islets. Western blot analysis showed that nesfatin-1 IR represented full length NUCB2 in rodent islets. Human islet NUCB2 mRNA was reduced in T2D subjects but upregulated after culture in glucolipotoxic conditions. Furthermore, a positive correlation between NUCB2 and glucagon and insulin gene expression, as well as insulin secretory capacity, was evident. Nesfatin-1 enhanced glucagon secretion but had no effect on insulin secretion from mouse islets or INS-1 (832/13) cells. On the other hand, nesfatin-1 caused a small increase in insulin secretion and reduced glucose during IVGTT in mice. We conclude that nesfatin-1 is a novel glucagon-stimulatory peptide expressed in the beta cell and that its expression is decreased in T2D islets.Nesfatin-1 is a novel anorexigenic regulatory peptide. The peptide is the N-terminal part of nucleobindin 2 (NUCB2) and is expressed in brain areas regulating feeding. Outside the brain, nesfatin-1 expression has been reported in adipocytes, gastric endocrine cells and islet cells. We studied NUCB2 expression in human and rodent islets using immunocytochemistry, in situ hybridization and western blot. Furthermore, we investigated the potential influence of nesfatin-1 on secretion of insulin and glucagon in vitro and in vivo in mice and in INS-1 (832/13) cells. The impact of type 2 diabetes (T2D) and glucolipotoxicity on NUCB2 gene expression in human islets and its relationship to insulin secretory capacity and islet gene expression was studied using microarray. Nesfatin-1 immunoreactivity (IR) was abundant in human and rodent beta cells but absent in alpha, delta, PP and ghrelin cells. Importantly, in situ hybridization showed that NUCB2 mRNA is expressed in human and rat islets. Western blot analysis showed that nesfatin-1 IR represented full length NUCB2 in rodent islets. Human islet NUCB2 mRNA was reduced in T2D subjects but upregulated after culture in glucolipotoxic conditions. Furthermore, a positive correlation between NUCB2 and glucagon and insulin gene expression, as well as insulin secretory capacity, was evident. Nesfatin-1 enhanced glucagon secretion but had no effect on insulin secretion from mouse islets or INS-1 (832/13) cells. On the other hand, nesfatin-1 caused a small increase in insulin secretion and reduced glucose during IVGTT in mice. We conclude that nesfatin-1 is a novel glucagon-stimulatory peptide expressed in the beta cell and that its expression is decreased in T2D islets. Nesfatin-1 is a novel anorexigenic regulatory peptide. The peptide is the N-terminal part of nucleobindin 2 (NUCB2) and is expressed in brain areas regulating feeding. Outside the brain, nesfatin-1 expression has been reported in adipocytes, gastric endocrine cells and islet cells. We studied NUCB2 expression in human and rodent islets using immunocytochemistry, in situ hybridization and western blot. Furthermore, we investigated the potential influence of nesfatin-1 on secretion of insulin and glucagon in vitro and in vivo in mice and in INS-1 (832/13) cells. The impact of type 2 diabetes (T2D) and glucolipotoxicity on NUCB2 gene expression in human islets and its relationship to insulin secretory capacity and islet gene expression was studied using microarray. Nesfatin-1 immunoreactivity (IR) was abundant in human and rodent beta cells but absent in alpha, delta, PP and ghrelin cells. Importantly, in situ hybridization showed that NUCB2 mRNA is expressed in human and rat islets. Western blot analysis showed that nesfatin-1 IR represented full length NUCB2 in rodent islets. Human islet NUCB2 mRNAwas reduced in T2D subjects but upregulated after culture in glucolipotoxic conditions. Furthermore, a positive correlation between NUCB2 and glucagon and insulin gene expression, as well as insulin secretory capacity, was evident. Nesfatin-1 enhanced glucagon secretion but had no effect on insulin secretion from mouse islets or INS-1 (832/13) cells. On the other hand, nesfatin-1 caused a small increase in insulin secretion and reduced glucose during IVGTT in mice. We conclude that nesfatin-1 is a novel glucagon-stimulatory peptide expressed in the beta cell and that its expression is decreased in T2D islets. Keywords Regulatory peptide * Human islets * Rodent islets * In situ hybridization * Immunochemistry Nesfatin-1 is a novel anorexigenic regulatory peptide. The peptide is the N-terminal part of nucleobindin 2 (NUCB2) and is expressed in brain areas regulating feeding. Outside the brain, nesfatin-1 expression has been reported in adipocytes, gastric endocrine cells and islet cells. We studied NUCB2 expression in human and rodent islets using immunocytochemistry, in situ hybridization and western blot. Furthermore, we investigated the potential influence of nesfatin-1 on secretion of insulin and glucagon in vitro and in vivo in mice and in INS-1 (832/13) cells. The impact of type 2 diabetes (T2D) and glucolipotoxicity on NUCB2 gene expression in human islets and its relationship to insulin secretory capacity and islet gene expression was studied using microarray. Nesfatin-1 immunoreactivity (IR) was abundant in human and rodent beta cells but absent in alpha, delta, PP and ghrelin cells. Importantly, in situ hybridization showed that NUCB2 mRNA is expressed in human and rat islets. Western blot analysis showed that nesfatin-1 IR represented full length NUCB2 in rodent islets. Human islet NUCB2 mRNAwas reduced in T2D subjects but upregulated after culture in glucolipotoxic conditions. Furthermore, a positive correlation between NUCB2 and glucagon and insulin gene expression, as well as insulin secretory capacity, was evident. Nesfatin-1 enhanced glucagon secretion but had no effect on insulin secretion from mouse islets or INS-1 (832/13) cells. On the other hand, nesfatin-1 caused a small increase in insulin secretion and reduced glucose during IVGTT in mice. We conclude that nesfatin-1 is a novel glucagon-stimulatory peptide expressed in the beta cell and that its expression is decreased in T2D islets. Nesfatin-1 is a novel anorexigenic regulatory peptide. The peptide is the N-terminal part of nucleobindin 2 (NUCB2) and is expressed in brain areas regulating feeding. Outside the brain, nesfatin-1 expression has been reported in adipocytes, gastric endocrine cells and islet cells. We studied NUCB2 expression in human and rodent islets using immunocytochemistry, in situ hybridization and western blot. Furthermore, we investigated the potential influence of nesfatin-1 on secretion of insulin and glucagon in vitro and in vivo in mice and in INS-1 (832/13) cells. The impact of type 2 diabetes (T2D) and glucolipotoxicity on NUCB2 gene expression in human islets and its relationship to insulin secretory capacity and islet gene expression was studied using microarray. Nesfatin-1 immunoreactivity (IR) was abundant in human and rodent beta cells but absent in alpha, delta, PP and ghrelin cells. Importantly, in situ hybridization showed that NUCB2 mRNA is expressed in human and rat islets. Western blot analysis showed that nesfatin-1 IR represented full length NUCB2 in rodent islets. Human islet NUCB2 mRNA was reduced in T2D subjects but upregulated after culture in glucolipotoxic conditions. Furthermore, a positive correlation between NUCB2 and glucagon and insulin gene expression, as well as insulin secretory capacity, was evident. Nesfatin-1 enhanced glucagon secretion but had no effect on insulin secretion from mouse islets or INS-1 (832/13) cells. On the other hand, nesfatin-1 caused a small increase in insulin secretion and reduced glucose during IVGTT in mice. We conclude that nesfatin-1 is a novel glucagon-stimulatory peptide expressed in the beta cell and that its expression is decreased in T2D islets.[PUBLICATION ABSTRACT] Nesfatin-1 is a novel anorexigenic regulatory peptide. The peptide is the N-terminal part of nucleobindin 2 (NUCB2) and is expressed in brain areas regulating feeding. Outside the brain, nesfatin-1 expression has been reported in adipocytes, gastric endocrine cells and islet cells. We studied NUCB2 expression in human and rodent islets using immunocytochemistry, in situ hybridization and western blot. Furthermore, we investigated the potential influence of nesfatin-1 on secretion of insulin and glucagon in vitro and in vivo in mice and in INS-1 (832/13) cells. The impact of type 2 diabetes (T2D) and glucolipotoxicity on NUCB2 gene expression in human islets and its relationship to insulin secretory capacity and islet gene expression was studied using microarray. Nesfatin-1 immunoreactivity (IR) was abundant in human and rodent beta cells but absent in alpha, delta, PP and ghrelin cells. Importantly, in situ hybridization showed that NUCB2 mRNA is expressed in human and rat islets. Western blot analysis showedthat nesfatin-1 IR represented full length NUCB2 in rodent islets. Human islet NUCB2 mRNA was reduced in T2D subjects but upregulated after culture in glucolipotoxic conditions. Furthermore, a positive correlation between NUCB2 and glucagon and insulin gene expression, as well as insulin secretory capacity, was evident. Nesfatin-1 enhanced glucagon secretion but had no effect on insulin secretion from mouse islets or INS-1 (832/13) cells. On the other hand, nesfatin-1 caused a small increase in insulin secretion and reduced glucose during IVGTT in mice. We conclude that nesfatin-1 is a novel glucagon-stimulatory peptide expressed in the beta cell and that its expression is decreased in T2D islets. |
| Audience | Academic |
| Author | Wierup, Nils Lindqvist, Andreas Sathanoori, Ramasri Voss, Ulrikke Nitert, Marloes Dekker Riva, Matteo Ling, Charlotte |
| Author_xml | – sequence: 1 fullname: Riva, Matteo – sequence: 2 fullname: Nitert, Marloes Dekker – sequence: 3 fullname: Voss, Ulrikke – sequence: 4 fullname: Sathanoori, Ramasri – sequence: 5 fullname: Lindqvist, Andreas – sequence: 6 fullname: Ling, Charlotte – sequence: 7 fullname: Wierup, Nils |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22108805$$D View this record in MEDLINE/PubMed https://lup.lub.lu.se/record/2220508$$DView record from Swedish Publication Index oai:portal.research.lu.se:publications/63211172-295a-478a-a31d-6309d4d35520$$DView record from Swedish Publication Index |
| BookMark | eNqNk0tv1DAUhSNURB_wA9iABRKwSfErTrwsFS-pKguoxM6ynZsZV55k8EOo_x6HTIFWUJEosnT1nWPnXN_Dam-cRqiqxwQfE4zb1xFjzkmNCakJFV3d3KsOCGe0xl3b7VUHmGFat0J83a8OY7zEmHAh5INqn1KCuw43B1U-hzjo5MaaoJjcJnudIKKVz1avphHpsUdujNm7EUWwAZLbVQ0kjSx4j84vTt9Q5CIK0GcLswCt80aPKF1tAVHUO11oZ1HM5hJsig-r-4P2ER7t1qPq4t3bL6cf6rNP7z-enpzVtm1wqtvGSCGaQUhsLRFUYKolwWBMa6xtKOOt6Ujb9aaXtAMiB0wNaa00nWgotOyo0otv_A7bbNQ2uI0OV2rSTm2nkLRXASLoYNfKZxVBFco7q-e_jEowSghpqaKy0Yq3nVaakb7Usex5z5qG4rLH2T_38HlbPrPz_k-7l4vdNkzfMsSkNi7OMesRphyVLJ3mnHWkkK_uJIksT8cbwQr67BZ6OeUwluhnP84IY3NYzxdopT0oNw5TCtrOnuqENVwyJpquUMd_ocrbw8bZcj8HV-o3BC_-EKxB-7SOk89LxDfAJ7tDZrOB_leQ15e1AO0C2DDFGGBQ1qWfrSpHcF4RrOaxUMtYqDIWah4LNSvJLeW1-V0auutrYccVhN-Z3SV6uogGPSm9Ci6qi8-0zF2ZPcax5OwHmTciHw |
| CitedBy_id | crossref_primary_10_1038_s41598_024_74371_y crossref_primary_10_1016_j_peptides_2015_06_002 crossref_primary_10_1210_js_2018_00246 crossref_primary_10_1016_j_pathophys_2016_12_001 crossref_primary_10_1016_j_mce_2013_05_003 crossref_primary_10_1371_journal_pone_0064882 crossref_primary_10_1016_j_ijbiomac_2020_03_110 crossref_primary_10_1111_jne_12899 crossref_primary_10_1016_j_peptides_2020_170308 crossref_primary_10_1016_j_npep_2022_102245 crossref_primary_10_1002_cbf_3877 crossref_primary_10_1159_000508883 crossref_primary_10_1089_met_2018_0010 crossref_primary_10_1007_s13105_022_00895_4 crossref_primary_10_1371_journal_pgen_1004235 crossref_primary_10_3389_fendo_2018_00633 crossref_primary_10_1530_JOE_16_0361 crossref_primary_10_1016_j_bionps_2024_100112 crossref_primary_10_1371_journal_pone_0071513 crossref_primary_10_61186_jspac_38828_2_5_14 crossref_primary_10_1007_s12576_019_00689_2 crossref_primary_10_1159_000496731 crossref_primary_10_1007_s13679_018_0318_7 crossref_primary_10_1111_obr_12063 crossref_primary_10_1007_s00592_016_0926_1 crossref_primary_10_1007_s12170_013_0370_5 crossref_primary_10_1016_j_coph_2016_08_012 crossref_primary_10_1590_1678_5150_pvb_7464 crossref_primary_10_1038_hr_2013_152 crossref_primary_10_5056_jnm16194 crossref_primary_10_1016_j_coph_2016_08_011 crossref_primary_10_3389_fphys_2018_01845 crossref_primary_10_1016_j_appet_2024_107669 crossref_primary_10_1210_en_2011_2032 crossref_primary_10_1016_j_coph_2014_06_006 crossref_primary_10_1186_s12917_024_04336_w crossref_primary_10_1016_j_cyto_2012_10_029 crossref_primary_10_1016_j_neuroscience_2015_11_062 crossref_primary_10_1155_2014_128014 crossref_primary_10_1016_j_advms_2022_07_005 crossref_primary_10_1016_j_mce_2015_04_016 crossref_primary_10_1016_j_ygcen_2021_113874 crossref_primary_10_3389_fendo_2018_00498 crossref_primary_10_1007_s13410_023_01297_y crossref_primary_10_1507_endocrj_EJ13_0236 crossref_primary_10_3892_etm_2024_12718 crossref_primary_10_1021_acs_jproteome_5b00587 crossref_primary_10_1186_s13098_017_0235_z crossref_primary_10_1186_s43162_022_00106_y crossref_primary_10_1016_j_cbpa_2019_05_024 crossref_primary_10_1016_j_phrs_2020_104766 crossref_primary_10_1210_en_2013_1497 crossref_primary_10_1007_s40618_019_01136_0 crossref_primary_10_1016_j_peptides_2017_07_001 crossref_primary_10_1007_s00441_014_1948_z crossref_primary_10_3892_mmr_2022_12894 crossref_primary_10_1002_jcla_22105 crossref_primary_10_1007_s00335_014_9538_7 crossref_primary_10_1111_j_1365_2826_2012_02375_x crossref_primary_10_3389_fpubh_2022_882686 crossref_primary_10_1007_s13410_020_00906_4 |
| Cites_doi | 10.1016/j.peptides.2007.10.008 10.1016/j.peptides.2007.09.005 10.1007/BF00314543 10.1210/jc.2006-2756 10.1210/en.2007-0701 10.1210/en.2009-1358 10.1016/S0167-0115(02)00067-8 10.1177/002215540405200301 10.1016/j.cmet.2009.09.002 10.1016/j.bbrc.2009.10.085 10.1507/endocrj.K09E-117 10.1016/j.bbrc.2009.02.104 10.1210/er.2006-0007 10.1126/science.1176827 10.1038/nature05162 10.2337/diabetes.49.3.424 10.1016/j.regpep.2005.02.016 10.1210/en.2008-0598 10.1038/ng.288 10.1210/en.2008-0747 10.1677/JOE-09-0254 10.1016/j.peptides.2009.11.019 10.1210/en.2010-1471 10.1507/endocrj.K11E-056 10.1016/j.regpep.2009.11.003 |
| ContentType | Journal Article |
| Copyright | Springer-Verlag 2011 COPYRIGHT 2011 Springer |
| Copyright_xml | – notice: Springer-Verlag 2011 – notice: COPYRIGHT 2011 Springer |
| CorporateAuthor | Neurogastroenterologi Kardiologi Department of Clinical Sciences, Lund Immunology Strategiska forskningsområden (SFO) Diabetes - epigenetik Medicinska fakulteten Cardiology Neurogastroenterology Diabetes - Epigenetics Immunologi Institutionen för kliniska vetenskaper, Lund Sektion II Lunds universitet Institutionen för experimentell medicinsk vetenskap Section II Profile areas and other strong research environments Department of Clinical Sciences, Malmö Lund University Department of Experimental Medical Science EXODIAB: Excellence of Diabetes Research in Sweden Faculty of Medicine Strategic research areas (SRA) Neuroendokrin cellbiologi Neuroendocrine Cell Biology Profilområden och andra starka forskningsmiljöer Institutionen för kliniska vetenskaper, Malmö |
| CorporateAuthor_xml | – name: Strategiska forskningsområden (SFO) – name: Department of Experimental Medical Science – name: Kardiologi – name: Section II – name: Neuroendocrine Cell Biology – name: Neurogastroenterology – name: Diabetes - epigenetik – name: Cardiology – name: Strategic research areas (SRA) – name: Department of Clinical Sciences, Lund – name: Lund University – name: EXODIAB: Excellence of Diabetes Research in Sweden – name: Profile areas and other strong research environments – name: Neuroendokrin cellbiologi – name: Department of Clinical Sciences, Malmö – name: Faculty of Medicine – name: Medicinska fakulteten – name: Diabetes - Epigenetics – name: Sektion II – name: Institutionen för kliniska vetenskaper, Malmö – name: Institutionen för kliniska vetenskaper, Lund – name: Lunds universitet – name: Neurogastroenterologi – name: Profilområden och andra starka forskningsmiljöer – name: Immunologi – name: Institutionen för experimentell medicinsk vetenskap – name: Immunology |
| DBID | FBQ AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7RV 7SS 7TK 7X7 7XB 88A 88E 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 7S9 L.6 7X8 ADTPV AOWAS D95 |
| DOI | 10.1007/s00441-011-1268-5 |
| DatabaseName | AGRIS CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Nursing & Allied Health Database Entomology Abstracts (Full archive) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Engineering Research Database ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Biological Science Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic SwePub SwePub Articles SWEPUB Lunds universitet |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Central Student AGRICOLA |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database – sequence: 4 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1432-0878 |
| EndPage | 405 |
| ExternalDocumentID | oai_portal_research_lu_se_publications_63211172_295a_478a_a31d_6309d4d35520 oai_lup_lub_lu_se_63211172_295a_478a_a31d_6309d4d35520 2545922291 A354933658 22108805 10_1007_s00441_011_1268_5 US201400134094 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C -~X .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3SX 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67N 67Z 6NX 78A 7RV 7X7 88A 88E 8AO 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AANXM AANZL AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABELW ABFGW ABFTV ABHLI ABHQN ABJNI ABJOX ABKAS ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABPTK ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHVE ACHXU ACIGE ACIPQ ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACTTH ACVWB ACWMK ADBBV ADHIR ADIMF ADINQ ADKNI ADKPE ADMDM ADOAH ADOXG ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AEQTP AESKC AESTI AETLH AEVLU AEVTX AEXYK AFDYV AFEXP AFGCZ AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG AOSHJ ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BKEYQ BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG EX3 F5P FBQ FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO IFM IHE IHR IHW IJ- IKXTQ INH INR ITC ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LK8 LLZTM M0L M1P M4Y M7P MA- MVM N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TSG TSK TSV TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 WOW X7M YLTOR Z45 Z7U Z7V Z7W Z82 Z83 Z87 Z8O Z8P Z8Q Z8V Z8W Z91 ZA5 ZGI ZMTXR ZOVNA ZXP ~EX ~KM AACDK AAHBH AAJBT AASML AAYZH ABAKF ABQSL ACAOD ACDTI ACPIV ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU ALIPV BSONS H13 PKN AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM AEIIB PMFND 7QP 7QR 7SS 7TK 7XB 8FD 8FK ABRTQ AZQEC DWQXO FR3 GNUQQ K9. P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7S9 L.6 7X8 ADTPV AOWAS D95 |
| ID | FETCH-LOGICAL-c750t-75b9665f690cc162602a910ebb7bcc52347b8178dbd928e19f02b17c9b8652e73 |
| IEDL.DBID | U2A |
| ISSN | 0302-766X 1432-0878 |
| IngestDate | Thu Aug 21 06:16:59 EDT 2025 Thu Jul 03 05:24:42 EDT 2025 Mon Jul 21 09:50:18 EDT 2025 Thu Jul 10 17:49:52 EDT 2025 Fri Jul 25 19:20:46 EDT 2025 Tue Jun 17 21:31:41 EDT 2025 Tue Jun 10 20:47:30 EDT 2025 Thu May 22 21:10:45 EDT 2025 Thu Apr 03 06:56:57 EDT 2025 Thu Apr 24 23:09:11 EDT 2025 Tue Jul 01 03:04:18 EDT 2025 Fri Feb 21 02:34:00 EST 2025 Wed Dec 27 19:12:08 EST 2023 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Human islets In situ hybridization Immunochemistry Regulatory peptide Rodent islets |
| Language | English |
| License | http://www.springer.com/tdm |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c750t-75b9665f690cc162602a910ebb7bcc52347b8178dbd928e19f02b17c9b8652e73 |
| Notes | http://dx.doi.org/10.1007/s00441-011-1268-5 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
| PMID | 22108805 |
| PQID | 912431337 |
| PQPubID | 49301 |
| PageCount | 13 |
| ParticipantIDs | swepub_primary_oai_portal_research_lu_se_publications_63211172_295a_478a_a31d_6309d4d35520 swepub_primary_oai_lup_lub_lu_se_63211172_295a_478a_a31d_6309d4d35520 proquest_miscellaneous_912644381 proquest_miscellaneous_1999984563 proquest_journals_912431337 gale_infotracmisc_A354933658 gale_infotracacademiconefile_A354933658 gale_healthsolutions_A354933658 pubmed_primary_22108805 crossref_citationtrail_10_1007_s00441_011_1268_5 crossref_primary_10_1007_s00441_011_1268_5 springer_journals_10_1007_s00441_011_1268_5 fao_agris_US201400134094 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2011-12-01 |
| PublicationDateYYYYMMDD | 2011-12-01 |
| PublicationDate_xml | – month: 12 year: 2011 text: 2011-12-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationTitle | Cell and tissue research |
| PublicationTitleAbbrev | Cell Tissue Res |
| PublicationTitleAlternate | Cell Tissue Res |
| PublicationYear | 2011 |
| Publisher | Springer-Verlag Springer Springer Nature B.V |
| Publisher_xml | – name: Springer-Verlag – name: Springer – name: Springer Nature B.V |
| References | Wierup, Björkqvist, Weström, Pierzynowski, Sundler, Sjölund (CR23) 2007; 92 Maejima, Sedbazar, Suyama, Kohno, Onaka, Takano, Yoshida, Koike, Uchiyama, Fujiwara, Yashiro, Horvath, Dietrich, Tanaka, Dezaki, Oh, Hashimoto, Shimizu, Nakata, Mori, Yada (CR11) 2009; 10 Price, Samson, Niehoff, Banks (CR16) 2007; 28 Wierup, Yang, McEvilly, Mulder, Sundler (CR26) 2004; 52 Ramanjaneya, Chen, Brown, Tripathi, Hallschmid, Patel, Kern, Hillhouse, Lehnert, Tan, Randeva (CR17) 2010; 151 Mulder, Lindh, Sundler (CR12) 1993; 274 Stengel, Goebel, Yakubov, Wang, Witcher, Coskun, Tache, Sachs, Lambrecht (CR22) 2009; 150 CR13 Stengel, Goebel, Wang, Tache (CR21) 2010; 31 Wierup, Svensson, Mulder, Sundler (CR25) 2002; 107 Li, Wang, Chen, Guan, Jiang (CR9) 2010; 159 Brailoiu, Dun, Brailoiu, Inan, Yang, Chang, Dun (CR1) 2007; 148 Gonzalez, Perry, Gao, Gaidhu, Tsushima, Ceddia, Unniappan (CR3) 2011a; 152 Gonzalez, Reingold, Gao, Gaidhu, Tsushima, Unniappan (CR4) 2011b; 208 Gonzalez, Tiwari, Unniappan (CR5) 2009; 381 Oh, Shimizu, Satoh, Okada, Adachi, Inoue, Eguchi, Yamamoto, Imaki, Hashimoto, Tsuchiya, Monden, Horiguchi, Yamada, Mori (CR14) 2006; 443 Rosengren, Jokubka, Tojjar, Granhall, Hansson, Li, Nagaraj, Reinbothe, Tuncel, Eliasson, Groop, Rorsman, Salehi, Lyssenko, Luthman, Renstrom (CR18) 2010; 327 Pan, Hsuchou, Kastin (CR15) 2007; 28 CR27 Shimizu, Oh, Hashimoto, Nakata, Yamamoto, Yoshida, Eguchi, Kato, Inoue, Satoh, Okada, Yamada, Yada, Mori (CR19) 2009a; 150 Foo, Brauner, Ostenson, Broberger (CR2) 2010; 204 Gromada, Franklin, Wollheim (CR6) 2007; 28 Hohmeier, Mulder, Chen, Henkel-Rieger, Prentki, Newgard (CR7) 2000; 49 Shimizu, Oh, Okada, Mori (CR20) 2009b; 56 Iwasaki, Nakabayashi, Kakei, Shimizu, Mori, Yada (CR8) 2009; 390 Wierup, Richards, Bannon, Kuhar, Ahren, Sundler (CR24) 2005; 129 Lyssenko, Nagorny, Erdos, Wierup, Jonsson, Spegel, Bugliani, Saxena, Fex, Pulizzi, Isomaa, Tuomi, Nilsson, Kuusisto, Tuomilehto, Boehnke, Altshuler, Sundler, Eriksson, Jackson, Laakso, Marchetti, Watanabe, Mulder, Groop (CR10) 2009; 41 M Ramanjaneya (1268_CR17) 2010; 151 TO Price (1268_CR16) 2007; 28 H Shimizu (1268_CR19) 2009a; 150 R Gonzalez (1268_CR4) 2011b; 208 N Wierup (1268_CR24) 2005; 129 IS Oh (1268_CR14) 2006; 443 Y Maejima (1268_CR11) 2009; 10 R Gonzalez (1268_CR3) 2011a; 152 A Stengel (1268_CR21) 2010; 31 H Mulder (1268_CR12) 1993; 274 A Stengel (1268_CR22) 2009; 150 H Shimizu (1268_CR20) 2009b; 56 1268_CR27 GC Brailoiu (1268_CR1) 2007; 148 N Wierup (1268_CR25) 2002; 107 1268_CR13 R Gonzalez (1268_CR5) 2009; 381 V Lyssenko (1268_CR10) 2009; 41 AH Rosengren (1268_CR18) 2010; 327 HE Hohmeier (1268_CR7) 2000; 49 Y Iwasaki (1268_CR8) 2009; 390 J Gromada (1268_CR6) 2007; 28 W Pan (1268_CR15) 2007; 28 1268_CR9 KS Foo (1268_CR2) 2010; 204 N Wierup (1268_CR23) 2007; 92 N Wierup (1268_CR26) 2004; 52 |
| References_xml | – volume: 28 start-page: 2372 year: 2007 end-page: 2381 ident: CR16 article-title: Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1 publication-title: Peptides doi: 10.1016/j.peptides.2007.10.008 – volume: 28 start-page: 2223 year: 2007 end-page: 2228 ident: CR15 article-title: Nesfatin-1 crosses the blood-brain barrier without saturation publication-title: Peptides doi: 10.1016/j.peptides.2007.09.005 – volume: 274 start-page: 467 year: 1993 end-page: 474 ident: CR12 article-title: Islet amyloid polypeptide gene expression in the endocrine pancreas of the rat: a combined in situ hybridization and immunocytochemical study publication-title: Cell Tissue Res doi: 10.1007/BF00314543 – volume: 92 start-page: 3573 year: 2007 end-page: 3581 ident: CR23 article-title: Ghrelin and motilin are cosecreted from a prominent endocrine cell population in the small intestine publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-2756 – volume: 148 start-page: 5088 year: 2007 end-page: 5094 ident: CR1 article-title: Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain publication-title: Endocrinology doi: 10.1210/en.2007-0701 – volume: 151 start-page: 3169 year: 2010 end-page: 3180 ident: CR17 article-title: Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity publication-title: Endocrinology doi: 10.1210/en.2009-1358 – volume: 208 start-page: R9 year: 2011b end-page: R16 ident: CR4 article-title: Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet beta- and MIN6 cells publication-title: J Endocrinol – volume: 107 start-page: 63 year: 2002 end-page: 69 ident: CR25 article-title: The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas publication-title: Regul Pept doi: 10.1016/S0167-0115(02)00067-8 – volume: 52 start-page: 301 year: 2004 end-page: 310 ident: CR26 article-title: Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells publication-title: J Histochem Cytochem doi: 10.1177/002215540405200301 – volume: 10 start-page: 355 year: 2009 end-page: 365 ident: CR11 article-title: Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway publication-title: Cell Metab doi: 10.1016/j.cmet.2009.09.002 – ident: CR27 – volume: 390 start-page: 958 year: 2009 end-page: 962 ident: CR8 article-title: Nesfatin-1 evokes Ca(2+) signaling in isolated vagal afferent neurons via Ca(2+) influx through N-type channels publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2009.10.085 – volume: 56 start-page: 537 year: 2009b end-page: 543 ident: CR20 article-title: Nesfatin-1: an overview and future clinical application publication-title: Endocr J doi: 10.1507/endocrj.K09E-117 – volume: 381 start-page: 643 year: 2009 end-page: 648 ident: CR5 article-title: Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2009.02.104 – volume: 28 start-page: 84 year: 2007 end-page: 116 ident: CR6 article-title: Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains publication-title: Endocr Rev doi: 10.1210/er.2006-0007 – volume: 327 start-page: 217 year: 2010 end-page: 220 ident: CR18 article-title: Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes publication-title: Science doi: 10.1126/science.1176827 – volume: 443 start-page: 709 year: 2006 end-page: 712 ident: CR14 article-title: Identification of nesfatin-1 as a satiety molecule in the hypothalamus publication-title: Nature doi: 10.1038/nature05162 – volume: 49 start-page: 424 year: 2000 end-page: 430 ident: CR7 article-title: Isolation of INS-1-derived cell lines with robust ATP-sensitive K + channel-dependent and -independent glucose-stimulated insulin secretion publication-title: Diabetes doi: 10.2337/diabetes.49.3.424 – volume: 129 start-page: 203 year: 2005 end-page: 211 ident: CR24 article-title: CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight publication-title: Regul Pept doi: 10.1016/j.regpep.2005.02.016 – ident: CR13 – volume: 150 start-page: 662 year: 2009a end-page: 671 ident: CR19 article-title: Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism publication-title: Endocrinology doi: 10.1210/en.2008-0598 – volume: 41 start-page: 82 year: 2009 end-page: 88 ident: CR10 article-title: Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion publication-title: Nat Genet doi: 10.1038/ng.288 – volume: 150 start-page: 232 year: 2009 end-page: 238 ident: CR22 article-title: Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa publication-title: Endocrinology doi: 10.1210/en.2008-0747 – volume: 204 start-page: 255 year: 2010 end-page: 263 ident: CR2 article-title: Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state publication-title: J Endocrinol doi: 10.1677/JOE-09-0254 – volume: 159 start-page: 72 year: 2010 end-page: 77 ident: CR9 article-title: Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans publication-title: Regul Pept – volume: 31 start-page: 357 year: 2010 end-page: 369 ident: CR21 article-title: Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight publication-title: Peptides doi: 10.1016/j.peptides.2009.11.019 – volume: 152 start-page: 3628 year: 2011a end-page: 3637 ident: CR3 article-title: Nutrient responsive nesfatin-1 regulates energy balance and induces glucose-stimulated insulin secretion in rats publication-title: Endocrinology doi: 10.1210/en.2010-1471 – volume: 31 start-page: 357 year: 2010 ident: 1268_CR21 publication-title: Peptides doi: 10.1016/j.peptides.2009.11.019 – volume: 390 start-page: 958 year: 2009 ident: 1268_CR8 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2009.10.085 – ident: 1268_CR13 doi: 10.1507/endocrj.K11E-056 – volume: 152 start-page: 3628 year: 2011a ident: 1268_CR3 publication-title: Endocrinology doi: 10.1210/en.2010-1471 – volume: 41 start-page: 82 year: 2009 ident: 1268_CR10 publication-title: Nat Genet doi: 10.1038/ng.288 – volume: 28 start-page: 2372 year: 2007 ident: 1268_CR16 publication-title: Peptides doi: 10.1016/j.peptides.2007.10.008 – volume: 327 start-page: 217 year: 2010 ident: 1268_CR18 publication-title: Science doi: 10.1126/science.1176827 – volume: 49 start-page: 424 year: 2000 ident: 1268_CR7 publication-title: Diabetes doi: 10.2337/diabetes.49.3.424 – volume: 28 start-page: 84 year: 2007 ident: 1268_CR6 publication-title: Endocr Rev doi: 10.1210/er.2006-0007 – volume: 274 start-page: 467 year: 1993 ident: 1268_CR12 publication-title: Cell Tissue Res doi: 10.1007/BF00314543 – volume: 10 start-page: 355 year: 2009 ident: 1268_CR11 publication-title: Cell Metab doi: 10.1016/j.cmet.2009.09.002 – volume: 107 start-page: 63 year: 2002 ident: 1268_CR25 publication-title: Regul Pept doi: 10.1016/S0167-0115(02)00067-8 – ident: 1268_CR9 doi: 10.1016/j.regpep.2009.11.003 – volume: 52 start-page: 301 year: 2004 ident: 1268_CR26 publication-title: J Histochem Cytochem doi: 10.1177/002215540405200301 – ident: 1268_CR27 – volume: 150 start-page: 662 year: 2009a ident: 1268_CR19 publication-title: Endocrinology doi: 10.1210/en.2008-0598 – volume: 56 start-page: 537 year: 2009b ident: 1268_CR20 publication-title: Endocr J doi: 10.1507/endocrj.K09E-117 – volume: 150 start-page: 232 year: 2009 ident: 1268_CR22 publication-title: Endocrinology doi: 10.1210/en.2008-0747 – volume: 381 start-page: 643 year: 2009 ident: 1268_CR5 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2009.02.104 – volume: 92 start-page: 3573 year: 2007 ident: 1268_CR23 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-2756 – volume: 28 start-page: 2223 year: 2007 ident: 1268_CR15 publication-title: Peptides doi: 10.1016/j.peptides.2007.09.005 – volume: 443 start-page: 709 year: 2006 ident: 1268_CR14 publication-title: Nature doi: 10.1038/nature05162 – volume: 129 start-page: 203 year: 2005 ident: 1268_CR24 publication-title: Regul Pept doi: 10.1016/j.regpep.2005.02.016 – volume: 151 start-page: 3169 year: 2010 ident: 1268_CR17 publication-title: Endocrinology doi: 10.1210/en.2009-1358 – volume: 208 start-page: R9 year: 2011b ident: 1268_CR4 publication-title: J Endocrinol – volume: 148 start-page: 5088 year: 2007 ident: 1268_CR1 publication-title: Endocrinology doi: 10.1210/en.2007-0701 – volume: 204 start-page: 255 year: 2010 ident: 1268_CR2 publication-title: J Endocrinol doi: 10.1677/JOE-09-0254 |
| SSID | ssj0014669 |
| Score | 2.3145528 |
| Snippet | Nesfatin-1 is a novel anorexigenic regulatory peptide. The peptide is the N-terminal part of nucleobindin 2 (NUCB2) and is expressed in brain areas regulating... |
| SourceID | swepub proquest gale pubmed crossref springer fao |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 393 |
| SubjectTerms | adipocytes Animals Biologi Biological Sciences Biomedical and Life Sciences Biomedicine biosynthesis brain Calcium-Binding Proteins Calcium-Binding Proteins - biosynthesis Calcium-Binding Proteins - genetics Calcium-Binding Proteins - metabolism Cell Biology Cellbiologi Cellular biology Dextrose Diabetes Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 2 - genetics Diabetes Mellitus, Type 2 - metabolism Diabetes Mellitus, Type 2 - physiopathology DNA-Binding Proteins DNA-Binding Proteins - biosynthesis DNA-Binding Proteins - genetics DNA-Binding Proteins - metabolism drug effects Female Gene expression gene expression regulation genetics ghrelin Glucagon Glucagon - genetics Glucagon - metabolism Glucose Glucose metabolism Glucose tolerance tests Human Genetics Humans immunocytochemistry Immunohistochemistry in situ hybridization Insulin Insulin - genetics Insulin - metabolism Insulin Secretion Insulin-Secreting Cells Insulin-Secreting Cells - drug effects Insulin-Secreting Cells - metabolism islets of Langerhans Islets of Langerhans - drug effects Islets of Langerhans - metabolism Male messenger RNA metabolism Mice Mice, Inbred C57BL microarray technology Molecular Medicine Natural Sciences Naturvetenskap Nerve Tissue Proteins Nerve Tissue Proteins - biosynthesis Nerve Tissue Proteins - genetics Nerve Tissue Proteins - metabolism noninsulin-dependent diabetes mellitus Pancreatic beta cells Peptides physiopathology Proteomics Rats Rats, Sprague-Dawley Regular Article RNA Rodents secretion Type 2 diabetes Western blotting |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZoERIXxLtpCxgJCQkUsXHsOD6hUrWqkNgLrLTiYtmOUyqVZGk2h_57ZmIndHmsOOSSON6s5-Hvs8czhLwCI6oNl3XqhGIp50akhgmf1kXheKVs5oaDwp_mxdmCf1yKZYzN6WJY5egTB0ddtQ7XyN8pmIhyIFTy_epHikWjcHM1VtDYIbcxcxlGdMnlxLfABwwV7UCNAUQWxXLc1JyFHKIceXSWZgzPHm1MSzu1af900TfmqGnT9LcEo8OkdHqf3Itokh4F8T8gt3zzkNwJ9SWvH5F-7rsahr5JMwqm_B1LdfmOYpi6OW8bapqKxmB02iF-RCkNd61fG4qL-nS-OP7A6EVHrzDJq8cX6FDYj-LqLWU0rN5eONr1Fhd1usdkcXry5fgsjXUWUgd4YZ1KYYH0iBqIsnMZMhxmAEV4a6V1Dpgql7bMZFnZSrHSZ6qeMZtJp2xZCOZl_oTsNm3j9_AEOOARZWtQAMWtqm1pPZAmp6RQpqhcQmbjMGsXk5BjLYxLPaVPHiSjQTIaJaNFQt5Mr6xCBo5tjfdAdtqcg4fUi88M-SOAXCSxCXmBAtXhfOlk2PooB4qc54DEEvJ6aIGmDR_lTDyhAH8Nk2RttDzcaAkm6TYeH4xKo6NL6PSkwAl5OT3FFzHKrfFt32lMCaFKgLR5Qug_2kA3AGEBZyXkaVDHaVQY0HdwxzAIb0f9_PXzW4bsJKjw1A9mHL_sV3BZuHTndZEzmBMl00wJo7ksjTZ5VsH9map4BZiVzRLy9S_9BBKpY-aqb7G_1Y0l6f_qfH_riB6QuyyYMlj0IdldX_X-GWDFtX0-eISfgZNe-Q priority: 102 providerName: ProQuest |
| Title | Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects |
| URI | https://link.springer.com/article/10.1007/s00441-011-1268-5 https://www.ncbi.nlm.nih.gov/pubmed/22108805 https://www.proquest.com/docview/912431337 https://www.proquest.com/docview/1999984563 https://www.proquest.com/docview/912644381 https://lup.lub.lu.se/record/2220508 oai:portal.research.lu.se:publications/63211172-295a-478a-a31d-6309d4d35520 |
| Volume | 346 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_RTUi8IL4XNoqRkJBAkRonjuPHbuqYQFQIqFR4sWzH2SaNtFqaB_577vLFCmOCh6hSYl8a34d_Z_vuAF6iEhUmkUXohOJhkhgRGi58WKSpS3JlI9cECn-YpyeL5N1SLLs47qo_7d5vSTaWegh2o71Hcn2jMOIULjSCXUGuOwrxgk-HrYMkberYofAidEzTZb-VeR2JrcloVJjVn4b5ysw0bJX-lla0mYqO78HdDkOyacv0-3DLlw_gdltV8sdDqOe-KnDAyzBiqMDfqUCXrxgdTjenq5KZMmfdEXRWEWok3jR3rd8YRkv5bL44OuTsvGKXlNrVUwfWlPNjtGbLOGvXbM8dq2pLSznVI1gcz74cnYRddYXQIUrYhFJYdHVEge6xcxH5NdwgdvDWSusc-qeJtFkks9zmimc-UsWE20g6ZbNUcC_jx7BTrkq_R3HfiEKULZDtKrGqsJn16Co5JYUyae4CmPTDrF2XepwqYFzoIWlywxmNnNHEGS0CeD10Wbd5N25qvIe80-YU7aJefObkNSK0Jdc1gOfEUN1GlQ7qrKcxOsZxjPgrgFdNC1Jo_FPOdHEJ-GmUGmur5cFWS1REt_V4vxca3RmCSivET3EUxzKAF8NT6khn20q_qitNiSBUhkA2DoD9pQ2SQeCK6CqAJ604DqPC0WlHI4yD8KaXz1-vv2HIZq0ID3Qoz_hFvcbL4qUrr9OY40woueZKGJ3IzGgTRznen6g8yRGp8kkA366h07qOustXddbRW19ZiP4n4k__65P24Q5vVRs1_AB2Npe1f4aIcWPHMJJLOYbd6duv72f4ezibf_w0buzGT7hPX-8 |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbarRBcEO-GFmokEBIoInGcOD4g1JattrRdIehKKy7GdpxSqWSXZleoP4r_yExedHmsuPSQS2JPEs945hvbM0PIU5hEueYi920smc-5jn3NYufnSWJ5Jk1oq0Dho2EyGPF343i8Qn60sTB4rLLViZWiziYW18hfSTBEEThU4s30m49Fo3Bzta2gUUvFgbv4Dh5b-Xr_LbD3GWN7_ePdgd8UFfAtGMeZL2IDCD_OwSu0NkQ4zzSYTGeMMNaCW8aFSUORZiaTLHWhzANmQmGlSZOYOREB3VWyxiPwZHpkbac_fP-h27bgSVVDDyYOwNYkGbfbqEGdtZSj5x76IcNopwVDuJrryZ9G4ZJV7LZpf0tpWpnBvVvkZoNf6XYtcLfJiivukGt1RcuLu2Q-dGUOzC78kILy-IrFwVxJ8WC8PpkUVBcZbY6_0xIRK8pFdde4maa4jUCHo90dRk9Leo5pZR12oFUpQYrrxZTRer341NJybnAZqbxHRlfChPukV0wKt44x54CApMlB5CQ3MjepceCmWSliqZPMeiRoh1nZJu05Vt84U13C5oozCjijkDMq9siLrsu0zvmxrPE68E7pE9DJavSRoccKsBrdZo9sIUNVHdHaqRK1HYFTHkWA_TzyvGqBygQ-yuomJgJ-DdNyLbTcXGgJSsAuPN5ohUY1SqhU3ZTxyJPuKXbEc3WFm8xLhUkoZAogOvII_UcbIAOgGZCdRx7U4tiNCmMhWKkABuFlK5-_Xr9kyPq1CHd0MMf52XwKl4FLlU4lEQMrLJhiMtaKi1QrHYUZ3A9kxjNAySzwyKe_0KndVtXkyvrS0JteWgT_L-IPl47oFrk-OD46VIf7w4MNcoPV0xpm9ybpzc7n7hEg1Zl53OgHSj5ftUr6CbCmm_o |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbaIhAXxLuhhRoJhASKmjhxHB8QKm1XLYUVEqy04mJsxymVSnZpdoX60_h3zMRJ6PJYcekhl8SZzXpe39ieGUKegBKVOhVlaLlkYZpqHmrGXVhmmU0LaWLbJAq_G2YHo_TNmI9XyI8uFwaPVXY2sTHUxcTiGvm2BEeUQEAltsv2VMT7vcGr6bcQG0jhRmvXTcNLyJE7_w7RW_3ycA9Y_ZSxwf7H3YOwbTAQWnCUs1BwA2iflxAhWhsjtGca3KczRhhrIURLhcljkRemkCx3sSwjZmJhpckzzpxIgO4quSISHqOKiXEf64H9abrpgQoBgM2ycbehGvn6pSnG8HEYM8x7WnCJq6We_OkeLvjHfsP2t-KmjUMc3CQ3WiRLd7zo3SIrrrpNrvrelud3yHzo6hLYXoUxBTPyFduEuZriEXl9PKmorgraHoSnNWJXlJDmrnEzTXFDgQ5Hu68ZPanpGRaYdfgCbZoKUlw5poz6leMTS-u5wQWl-i4ZXQoL7pG1alK5dcw-BywkTQnCJ1MjS5MbBwGblYJLnRU2IFE3zcq2BdCxD8ep6ks3N5xRwBmFnFE8IM_7V6a--seywevAO6WPwTqr0QeGsSsAbAygA7KFDFU-t7U3KmongfA8SQAFBuRZMwLNCnyU1W12BPw1LNC1MHJzYSSYA7vweKMTGtWao1r1yhOQx_1TfBFP2FVuMq8VlqOQOcDpJCD0H2OADMBnwHgBue_FsZ8VxmLwVxFMwotOPn_9_JIp2_ci3NPBauen8ylcBi5VO5UlDPyxYIpJrlUqcq10EhdwP5JFWgBeZlFAPv2Fjg9gVVs160tLb3phOfy_iD9YOqNb5BoYIvX2cHi0Qa4zr9Wg3JtkbXY2dw8Bss7Mo8Y4UPL5sq3RT5_enso |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nesfatin-1+stimulates+glucagon+and+insulin+secretion+and+beta+cell+NUCB2+is+reduced+in+human+type+2+diabetic+subjects&rft.jtitle=Cell+and+tissue+research&rft.au=Riva%2C+Matteo&rft.au=Nitert%2C+Marloes+Dekker&rft.au=Voss%2C+Ulrikke&rft.au=Sathanoori%2C+Ramasri&rft.date=2011-12-01&rft.pub=Springer-Verlag&rft.issn=0302-766X&rft.eissn=1432-0878&rft.volume=346&rft.issue=3&rft.spage=393&rft.epage=405&rft_id=info:doi/10.1007%2Fs00441-011-1268-5&rft.externalDocID=10_1007_s00441_011_1268_5 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0302-766X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0302-766X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0302-766X&client=summon |